CPT1A and nasopharyngeal carcinoma: PPARγ coactivator-1α forms a complex with CCAAT/enhancer-binding protein β to promote CPT1A transcription, driving CPT1A overexpression and radioresistance in nasopharyngeal carcinoma [121].